Impact of pre-enrolment medication use on clinical outcomes in SUMMIT

ERJ Open Research
Jørgen VestboPeter Lange

Abstract

The impact of prior treatment on results of clinical trials in chronic obstructive pulmonary disease (COPD) has been debated. We used data from the Study to Understand Mortality and Morbidity in COPD Trial to examine the impact of prior treatment on the effects of randomised study drugs on mortality and exacerbations. We used data on 16 417 patients with moderate COPD and heightened cardiovascular risk and information on prior medications to examine the effects of fluticasone furoate (FF), vilanterol (VI) and combined FF/VI compared to placebo on moderate and severe exacerbation as well as mortality. The study was event-driven with a median study exposure of 1.8 years. This study was registered with ClinicalTrials.gov, number NCT01313676. There were no consistent associations between treatment prior to study entry and the effects of FF, VI or FF/VI on exacerbations during the study. However, patients taking inhaled corticosteroids and one or more bronchodilators prior to study entry seemed to have a better effect of active treatments than of placebo on mortality (hazard ratio for FF/VI 0.65, 95% CI 0.48-0.89). Survival in those randomised to placebo was independent of treatment prior to study enrolment. Prior treatment appears ...Continue Reading

References

Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Dec 29, 2007·Respiratory Research·Aklak B ChoudhuryChris J Griffiths
Jan 25, 2008·The European Respiratory Journal·S SuissaS D Aaron
Oct 7, 2008·The New England Journal of Medicine·Donald P TashkinUNKNOWN UPLIFT Study Investigators
Nov 3, 2009·The European Respiratory Journal·O N KeeneP W Jones
Jun 2, 2011·Respiratory Research·Paul W JonesUNKNOWN TORCH investigators
Feb 25, 2014·Thorax·Samy Suissa
Sep 10, 2014·The New England Journal of Medicine·Helgo MagnussenUNKNOWN WISDOM Investigators
Dec 30, 2014·The European Respiratory Journal·Pierre ErnstSamy Suissa
Apr 4, 2015·Chest·Lisette I Z KunzUNKNOWN GLUCOLD Study Group
Sep 7, 2017·The New England Journal of Medicine·Yumin ZhouPixin Ran
Sep 28, 2017·American Journal of Respiratory and Critical Care Medicine·Samy Suissa, Amnon Ariel
Sep 28, 2017·American Journal of Respiratory and Critical Care Medicine·David A LipsonSteven J Pascoe
Dec 15, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Peter Ma CalverleyAntonio Anzueto

❮ Previous
Next ❯

Citations

Mar 28, 2020·American Journal of Respiratory and Critical Care Medicine·Jørgen Vestbo
Mar 13, 2020·American Journal of Respiratory and Critical Care Medicine·David A LipsonFernando J Martinez

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01313676

Software Mentioned

SUMMIT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.